Global Ribonucleic Acid (RNA) Markers Market – Industry Trends and Forecast to 2030

Ribonucleic Acid (RNA) Markers Market Analysis and Size

The growing popularity of personalized medicines for treating chronic diseases and genetic disorders is a primary factor leading to the growth of RNA markers. These markers are important in researching and developing several new therapies and drugs, which have increased over the years. The growing number of biotech companies in the U.S. are getting increasingly involved with the production of RNA biomarkers with each passing decade.  

Data Bridge Market Research analyses that the ribonucleic acid (RNA) markers market, which was USD 500 million in 2022, would rise to USD 960.30 million by 2030 and is expected to undergo a CAGR of 8.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Ribonucleic Acid (RNA) Markers Market Scope and Segmentation

Market Definition

RNA markers are a bunch of ribonucleic acid transcripts that are specially synthesized from pre-specified templates for in vitro identification and analysis. These markers are widely used for identifying and isolating relative molecular mass analysis and are just not used specifically for evaluating various molecules. These markers give a measurable scale of relative molecular mass that gives the fragment size of molecules through gel action.

Global Ribonucleic Acid (RNA) Markers Market Dynamics

Drivers

• Increasing Investments by Market Players in R&D Activities

The growing investment by pharmaceutical companies in molecular biology research and development, and development in proteomics research and genomics, will boost the market in the near future. For instance, the Magnotta Foundation contributed around USD 1.4 million to Lyme disease research using molecular markers. The University of Leeds invested USD 21.25 million in structural biology research, which is anticipated to include molecular markers in research activities in more than 50% of the cases. Huge investments in research in particular areas, including RNA markers, and increasing stress on molecular research biology, are estimated to boost the market growth. Thus, this factor boosts market growth.

Opportunities

• Increasing Technological Advancements in Molecular Biomarkers

Several technological advancements in molecular biology products, such as NGS and PCR, along with high-quality molecular weight markers, are another primary factor leading to the market growth. The latest advancement in these products provides a clearer background and sharp bands. Therefore, the demand for RNA marker products is anticipated to surge soon, which is expected to boost growth.

• Growing Strategic Collaborations With Ribonucleic Acid (RNA) Markers

There is a huge number of collaborations that are done between market players that lead to market growth. For instance, Moderna, Inc. and Thermo Fisher Scientific, Inc. announced their strategic collaboration to operate a large-scale manufacturing unit of Moderna's COVID-19 vaccine in the U.S., combined with numerous other mRNA medicines in 2022. Also, Agilent Technologies, Inc. collaborated with APC Ltd. in 2022, enabling a suitable workflow that supports automated process analysis using liquid chromatography for consumers. Thus, this factor boosts market growth.

Restraints/Challenges

• High treatment costs of Ribonucleic Acid (RNA) Markers

The complications, such as high investment requirements, high treatment costs, and expensive capital expenditure on multiple diagnostic equipment, are anticipated to limit market expansion. The equipment is not always affordable in underdeveloped nations. Thus, this factor restricts the market growth. Therefore, these factors hamper the market growth.

This ribonucleic acid (RNA) markers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ribonucleic acid (RNA) markers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Ribonucleic Acid (RNA) Markers Market Scope

The ribonucleic acid (RNA) markers market is segmented on the basis of type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Prestained Markers
• Unstained Markers
• Specialty Markers

 Application

• Nucleic Acid
• Proteomics

End User

• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Cathode-Ray Oscilloscope
• Others

Ribonucleic Acid (RNA) Markers Market Regional Analysis/Insights

The ribonucleic acid (RNA) markers market is analyzed and market size insights and trends are provided by type, application, and end user as referenced above.

The countries covered in the ribonucleic acid (RNA) markers market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the ribonucleic acid (RNA) markers market because of the utilization of the applicable molecular analysis, and growth witnessed across the numerous end users is anticipated to be the primary factor behind the largest market share in the region.       

Asia-Pacific is expected to grow significantly due to the high adoption rate for advanced analytical and research instruments and techniques in this region. Furthermore, increasing research activities in the region, the increasing prevalence of cancer, and the high demand for quality healthcare are boosting market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The ribonucleic acid (RNA) markers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ribonucleic acid (RNA) markers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ribonucleic acid (RNA) markers market. The data is available for historic period 2011-2021.

Competitive Landscape and Ribonucleic Acid (RNA) Markers Market Share Analysis

The ribonucleic acid (RNA) markers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to ribonucleic acid (RNA) markers market.

Some of the major players operating in the ribonucleic acid (RNA) markers market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Thermo Fisher Scientific (U.S.)
• Abbott (U.S.)
• QIAGEN (Germany)
• PerkinElmer, Inc. (U.S.)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Enzo Biochem, Inc. (U.S)
• Eurofins Scientific (Luxembourg)
• Agilent Technologies, Inc. (U.S.)
• Bruker (U.S.)
• Siemens (U.S.)
• General Electric (U.S.
• Lonza (Switzerland)
• ZOLL Medical Corporation (U.S.)
• Promega Corporation (U.S.)

SKU-51723